Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced it...
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
Karyopharm Therapeutics (NASDAQ:KPTI – Get Rating) and Inventiva (NASDAQ:IVA – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Profitability This table compares Karyopharm Therapeutics and Inventiva’s net margins, […]
Wall Street analysts expect Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) to announce sales of $35.14 million for the current quarter, according to Zacks. Six analysts have made estimates for Karyopharm Therapeutics’ earnings. The highest sales estimate is $37.23 million and the lowest is $31.33 million. Karyopharm Therapeutics reported sales of $23.26 million in the […]